Juan Zhou

1.3k total citations · 1 hit paper
74 papers, 837 citations indexed

About

Juan Zhou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Juan Zhou has authored 74 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Juan Zhou's work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Research Studies (9 papers). Juan Zhou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Research Studies (9 papers). Juan Zhou collaborates with scholars based in China, United States and United Kingdom. Juan Zhou's co-authors include Chunxia Su, Jing Zhao, Fei Zhou, Xin Yu, Caicun Zhou, Shengxiang Ren, Thomas D. Wang, Wensou Huang, Licong Liang and Liteng Lin and has published in prestigious journals such as Gut, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Juan Zhou

64 papers receiving 829 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study

2022 117 citations Mingyue Cai, Juan Zhou et al. profile →

Peers

Countries citing papers authored by Juan Zhou

Since Specialization

Citations

This map shows the geographic impact of Juan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Zhou more than expected).

Fields of papers citing papers by Juan Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Zhou. The network helps show where Juan Zhou may publish in the future.

Co-authorship network of co-authors of Juan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Zhou. A scholar is included among the top collaborators of Juan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Zhou. Juan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of cellular senescence-associated genes for predicting the diagnosis, prognosis and immunotherapy response in lung adenocarcinoma via a 113-combination machine learning framework 2025 ·Discover Oncology ·Ting Ge, (unknown), Qian Cui, (unknown), Zekun Wang, Yingying Xie, (unknown), Juan Zhou, Jianchun Yu, Jun Hu, Wentao Li	0
2	Assessment of the Impact of Co-Applicationof Spent Mushroom Substrate-Based Bio-OrganicFertilizer and Compound Fertilizer on PassionFruit, Rhizosphere Soil, and Microbiota 2025 ·Polish Journal of Environmental Studies ·(unknown), (unknown), (unknown), (unknown), Juan Zhou, Shaoqi Zhou	0
3	VAV2 exists in extrachromosomal circular DNA and contributes Enzalutamide resistance of prostate cancer via stabilization of AR/ARv7 2025 ·International Journal of Biological Sciences ·(unknown), Xinan Wang, (unknown), (unknown), Haopeng Li, Xin Qin, Yan Zhao, Wei Jiang, Mingming Xu, (unknown), Xilei Li, Xi Chen, Juan Zhou, Gang Wu	5
4	Case report: Pyrotinib in the treatment of advanced scrotal EMPD combined with sweat gland carcinoma 2024 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Wei Wang, Lei Yue, Ning Yang, (unknown), Peng Liu, Juan Zhou, (unknown)	0
5	975P Lenvatinib plus drug-eluting bead transarterial chemoembolization with or without hepatic arterial infusion chemotherapy for hepatocellular carcinoma (> 7 cm) with portal vein tumor thrombosis: A retrospective multicenter cohort study 2024 ·Annals of Oncology ·Mingyue Cai, Liping Liang, Hui Chen, Jing Zhang, Ning Chen, Wei-Feng Huang, Yu Guo, Lin Li, Yi Liu, Dan Chen, Xinhui Liu, Juan Zhou, Yong Chen, Kangshun Zhu	1
6	A muti-modal feature fusion method based on deep learning for predicting immunotherapy response 2024 ·Journal of Theoretical Biology ·(unknown), Xuan Feng, Juan Zhou, (unknown), Xiao Chen, (unknown), (unknown), Guoming Xiong, Guoliang Luo	5
7	Extracellular Vesicles for Drug Delivery in Cancer Treatment 2023 ·Biological Procedures Online ·Li Wang, Xin Yu, Juan Zhou, Chunxia Su	30
8	Multiple CD59 Polymorphisms in Chinese Patients with Mycobacterium tuberculosis Infection 2023 ·Journal of Immunology Research ·Jie Tang, Zhenzhen Zhao, Juan Zhou, Lin Jiao, (unknown), Binwu Ying, Yuwei Yang	0
9	Establishment of an acquired lorlatinib-resistant cell line of non-small cell lung cancer and its mediated resistance mechanism 2022 ·Clinical & Translational Oncology ·Bo Xie, Ying Qiu, Juan Zhou, Dou Du, (unknown), Jiapeng Ji, Liquan Zhu, (unknown)	1
10	Clinical and Endoscopic Characteristics of Chinese Cronkhite-Canada Syndrome Patients: A Retrospective Study of 103 Cases 2021 ·Digestive Diseases ·Yuanyuan Lu, (unknown), Youwei Wang, Juan Zhou, Qiu Zhao, Lan Liu	8
11	Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer 2021 ·Frontiers in Oncology ·Juan Zhou, Jing Zhao, Qingzhu Jia, Qian Chu, Fei Zhou, (unknown), Wencheng Zhao, Shengxiang Ren, Caicun Zhou, Chunxia Su	15
12	Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy 2021 ·Translational Lung Cancer Research ·Xin Yu, Jiaqi Li, Lingyun Ye, Jing Zhao, (unknown), Juan Zhou, Yinchen Shen, Fei Zhou, Yan Wu, (unknown), Jialin Qian, Tianqing Chu, Chunxia Su	13
13	Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases 2020 ·Translational Lung Cancer Research ·Juan Zhou, Fei Zhou, (unknown), Jing Zhao, Yan Wu, Wencheng Zhao, Chuan Xu, Chunxia Su	14
14	Detection of colonic neoplasia in vivo using near-infrared-labeled peptide targeting cMet 2019 ·Scientific Reports ·Xiaoli Wu, Juan Zhou, (unknown), Xiaoqing Meng, Jing Chen, (unknown), (unknown), Gaoming Li, Xue Li, Henry D. Appelman, Rork Kuick, Thomas D. Wang	10
15	Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China 2019 ·World Journal of Pediatrics ·Dawei Liu, (unknown), Xuemei Tang, Yu Zhang, Juan Zhou	3
16	In vivo near-infrared imaging of ErbB2 expressing breast tumors with dual-axes confocal endomicroscopy using a targeted peptide 2017 ·Scientific Reports ·Zhenghong Gao, Gaoming Li, Xue Li, Juan Zhou, Xiyu Duan, Jing Chen, Bishnu Joshi, Rork Kuick, Basma Khoury, Dafydd G. Thomas, (unknown), Michael S. Sabel, Henry D. Appelman, Quan Zhou, Haijun Li, Ken Kozloff, Thomas D. Wang	10
17	Clinical Features and Drug-Resistance Profile of Urinary Tuberculosis in South-Western China 2016 ·Medicine ·Yuanxin Ye, Xuejiao Hu, Yunying Shi, Juan Zhou, Yi Zhou, Xingbo Song, (unknown), Xiaojun Lu, Lanlan Wang, Binwu Ying, Xuerong Chen	11
18	Clinical efficacy of administering oxaliplatin combined with S-1 in the treatment of advanced triple-negative breast cancer 2015 ·Experimental and Therapeutic Medicine ·Jun Liu, Yang Xiao, (unknown), Jianxiong Guo, Yangchen Liu, Xiaohong Huang, (unknown), (unknown), Juan Zhou	7
19	Human Stromal Cells in the Peripheral Zone of the Prostate Promote Tumorigenesis of Prostatic Cancer Stem Cells through Up-regulation of C-Kit Expression 2015 ·Journal of Cancer ·Yubing Peng, Qi Chen, Meng Gu, Yanbo Chen, Ming Zhang, Juan Zhou, Hao Wang, Yan Gao, Wenji Li, Zhong Wang, Zhikang Cai	10
20	Post-mastectomy radiotherapy can improve survival in breast cancer patients aged 35 years or younger with four or more positive nodes but not in one to three positive nodes 2014 ·Therapeutics and Clinical Risk Management ·(unknown), Juan Zhou, (unknown), Feng‐Yan Li, Qin Lin, Qun Li, San‐Gang Wu	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact